Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Momenta Pharmaceuticals, Inc. (MNTA)

« Back to company index

MNTA Chatter Timeline

Stock Ticker for MNTA

Most Active Tweeters for MNTA

UserTweets
@AmericanBanking 5
@dispatchtribune 3
@gmion11 3
@1MinuteStock 3
@StockWatchHQ 3

Recent Tweets for MNTA

gmion11 @gmion11
$AMPH $MNTA AMPHvMNTA 1:16-cv-10112 updated - 5/23/2019 10:59:26 - ELECTRONIC NOTICE Canceling Hearing. 5/28/19 Mot… https://t.co/BPmVJDXZYi
May 23rd 2019, 10:05am
AmericanBanking @AmericanBanking
Momenta Pharmaceuticals, Inc. $MNTA Given Average Rating of “Hold” by Analysts https://t.co/hQkSUZaNqa #stocks
May 23rd 2019, 10:05am
TickerReport @TickerReport
Momenta Pharmaceuticals, Inc. $MNTA Receives Average Recommendation of “Hold” from Analysts https://t.co/GyDbwSeibE
May 23rd 2019, 10:05am
StockWatchHQ @StockWatchHQ
RT @StockWatchHQ: Momenta Pharmaceuticals $MNTA CEO Announcement On Acquisition Discussions With AbbVie $ABBV https://t.co/3tIatPbVB0 The…
May 22nd 2019, 9:05am
StockWatchHQ @StockWatchHQ
Momenta Pharmaceuticals $MNTA CEO Announcement On Acquisition Discussions With AbbVie $ABBV https://t.co/3tIatPbVB0… https://t.co/GwF7IhFqgN
May 21st 2019, 10:05pm
gmion11 @gmion11
$AMPH $MNTA AMPHvMNTA 1:16-cv-10112 updated - 5/21/2019 14:02:10 - Joint MOTION to Stay by Momenta Pharmaceuticals… https://t.co/ggLYYRZgZk
May 21st 2019, 2:05pm
gmion11 @gmion11
$AMPH $MNTA AMPHvMNTA 1:16-cv-10112 updated - 5/20/2019 13:58:45 - Joint MOTION to Adjourn Hearing Scheduled For Ma… https://t.co/lIZj8eYYV6
May 20th 2019, 1:05pm
1MinuteStock @1MinuteStock
We calculated 63-day Expected Return of $MNTA for you: 0.2% https://t.co/UqkLvY5zm0
May 19th 2019, 4:05pm
FlyOnTheWallHQ @FlyOnTheWallHQ
RT @StockWatchHQ: Momenta Pharmaceuticals $MNTA Makes Offer For BioTime $BTX, Board Of Directors To Vote This Week https://t.co/cXADKtHwNi…
May 19th 2019, 2:05pm
1MinuteStock @1MinuteStock
Explore #fundamental numbers and pros and cons for $MNTA https://t.co/c6wLKcAMLQ
May 19th 2019, 2:05pm
StockWatchHQ @StockWatchHQ
Momenta Pharmaceuticals $MNTA Makes Offer For BioTime $BTX, Board Of Directors To Vote This Week… https://t.co/HUE7eHsCH8
May 18th 2019, 9:05pm
ChartMill @ChartMill
Although the technical rating is bad, $MNTA does present a nice setup opportunity. https://t.co/kF0RtbbAzl https://t.co/T52itpDJ8x
May 17th 2019, 7:05pm
Stock_News_Now @Stock_News_Now
$MNTA: New SEC Filing for MNTA: Form DEFA14A (No. 0001047469-19-003184): https://t.co/hO9mMZ45vy
May 17th 2019, 4:05pm
Allstocknews @Allstocknews
$MNTA New Form DEFA14A for Momenta Pharmaceuticals From our Stock News Alerts App
May 17th 2019, 4:05pm
ResearchPool @ResearchPool
$MNTA #Momenta Pharmaceuticals Inc. Morningstar | Momenta Under Review. See Updated Analyst Note from 06 May 2019:… https://t.co/8lk0AT0RIp
May 17th 2019, 1:05pm
OlympiaReport @OlympiaReport
Insider Selling: Momenta Pharmaceuticals, Inc. $MNTA CEO Sells 2,778 Shares of Stock https://t.co/eTiiGmPylb
May 17th 2019, 12:05pm
WeekHerald @WeekHerald
Insider Selling: Momenta Pharmaceuticals, Inc. $MNTA CEO Sells 2,778 Shares of Stock https://t.co/ccQxWKKeLS
May 16th 2019, 4:05pm
dispatchtribune @dispatchtribune
Momenta Pharmaceuticals, Inc. $MNTA CEO Sells $25,038.36 in Stock https://t.co/xYpIKGTvMm
May 16th 2019, 12:05pm
AmericanBanking @AmericanBanking
Insider Selling: Momenta Pharmaceuticals, Inc. $MNTA CEO Sells 2,778 Shares of Stock https://t.co/twJ90n1PHC #stocks
May 15th 2019, 9:05pm
InsiderAlertsIA @InsiderAlertsIA
$MNTA: New Insider Filing on President & CEO CRAIG A WHEELER: https://t.co/v2Si5fTqaR
May 15th 2019, 7:05pm
StockTexts @StockTexts
$MNTA Momenta Pharmaceuticals, Inc. SEC Filing: Form 4 https://t.co/H6MWa5uI8Z
May 15th 2019, 7:05pm
dakotafinancial @dakotafinancial
Momenta Pharmaceuticals, Inc. $MNTA Expected to Post Earnings of -$0.42 Per Share https://t.co/S4QJAqcpf4
May 15th 2019, 5:05pm
intercooleronli @intercooleronli
Insider Selling: Momenta Pharmaceuticals, Inc. $MNTA CEO Sells 1,772 Shares of Stock https://t.co/M0gF5ZCZoG #investingnews
May 15th 2019, 12:05pm
ledgerzette @ledgerzette
Insider Selling: Momenta Pharmaceuticals, Inc. $MNTA CEO Sells 1,772 Shares of Stock https://t.co/MlLZMstlQe #stocks
May 15th 2019, 12:05pm
AnnemarieVtW @AnnemarieVtW
RT @ZacharyBrennan: Fresenius - Sept. 30, 2023 (can launch in EU when approved) $MNTA - Nov. 20, 2023 (can launch in EU when approved) $PFE…
May 15th 2019, 3:05am
AmericanBanking @AmericanBanking
Craig A. Wheeler Sells 1,772 Shares of Momenta Pharmaceuticals, Inc. $MNTA Stock https://t.co/Y2KAjxDvuT #stocks
May 14th 2019, 9:05pm
AmericanBanking @AmericanBanking
Investment Analysts’ Weekly Ratings Changes for Momenta Pharmaceuticals $MNTA https://t.co/KUX8x76nci #stocks
May 14th 2019, 7:05pm
InsiderAlertsIA @InsiderAlertsIA
$MNTA: New Insider Filing on President & CEO CRAIG A WHEELER: https://t.co/HcQgaM8rS4
May 14th 2019, 7:05pm
insiderbuyings @insiderbuyings
$MNTA new insider selling: 114 shares. https://t.co/kI2r2vIGKp
May 14th 2019, 7:05pm
Allstocknews @Allstocknews
$MNTA New Form 4/A for Momenta Pharmaceuticals From our Stock News Alerts App
May 14th 2019, 6:05pm
dailypoliticaln @dailypoliticaln
Momenta Pharmaceuticals, Inc. $MNTA Expected to Announce Earnings of -$0.42 Per Share https://t.co/Ab3FcxOl6I
May 13th 2019, 2:05pm
ZolmaxNews @ZolmaxNews
Brokerages Expect Momenta Pharmaceuticals, Inc. $MNTA Will Post Quarterly Sales of $9.10 Million https://t.co/Cv6mUn0R5c
May 13th 2019, 2:05pm
TheMarketsDaily @TheMarketsDaily
Momenta Pharmaceuticals $MNTA Downgraded by Zacks Investment Research https://t.co/2zHTLgDnCS
May 13th 2019, 9:05am
TranscriptDaily @TranscriptDaily
Momenta Pharmaceuticals $MNTA Downgraded by Zacks Investment Research to Hold https://t.co/3WjZJ5U20y
May 13th 2019, 9:05am
SleekMoneycom @SleekMoneycom
Momenta Pharmaceuticals $MNTA Downgraded by Zacks Investment Research https://t.co/bofQ0rnvlk #investing
May 13th 2019, 9:05am
stocknewstimes @stocknewstimes
Momenta Pharmaceuticals $MNTA Downgraded by Zacks Investment Research https://t.co/xMzbXtyHtB
May 13th 2019, 9:05am
ChartMill @ChartMill
$MNTA has a Current Ratio of 6.71, so it is financially healthy and has no problem in meeting its obligations.… https://t.co/7pTLStmKjs
May 13th 2019, 2:05am
ConsumerFeed @ConsumerFeed
Momenta Pharmaceuticals $MNTA Downgraded to Hold at Zacks Investment Research https://t.co/VENBCSKjbj
May 12th 2019, 12:05pm
WatchlistN @WatchlistN
Insider Selling: Momenta Pharmaceuticals, Inc. $MNTA CEO Sells 2,601 Shares of Stock https://t.co/cj1NgwDD06
May 12th 2019, 11:05am
chiragontwtr @chiragontwtr
@JohnCendpts Didn't know $MNTA's partner CSL is this big. Only new entrant in the top 20 list.
May 12th 2019, 5:05am
1MinuteStock @1MinuteStock
Unicorn Bay rating for $MNTA is 2.69 out of 5. https://t.co/u2PmxjYkyT
May 12th 2019, 4:05am
dispatchtribune @dispatchtribune
Zacks Investment Research Lowers Momenta Pharmaceuticals $MNTA to Hold https://t.co/eBoUy19Vdr
May 11th 2019, 12:05pm
TranscriptDaily @TranscriptDaily
Momenta Pharmaceuticals, Inc. $MNTA CEO Sells $36,361.98 in Stock https://t.co/CgeSM99UTf
May 11th 2019, 11:05am
dispatchtribune @dispatchtribune
Brokerages Expect Momenta Pharmaceuticals, Inc. $MNTA to Post -$0.42 Earnings Per Share https://t.co/AGxQamjCOl
May 11th 2019, 5:05am
ThisLincolnian @ThisLincolnian
Momenta Pharmaceuticals, Inc. $MNTA CEO Sells $36,361.98 in Stock https://t.co/5Kh2drm3CP
May 10th 2019, 3:05pm
AmericanBanking @AmericanBanking
Analysts Anticipate Momenta Pharmaceuticals, Inc. $MNTA Will Post Quarterly Sales of $9.10 Million https://t.co/BahItGe79z #stocks
May 10th 2019, 3:05am
AmericanBanking @AmericanBanking
Momenta Pharmaceuticals, Inc. $MNTA CEO Sells $36,361.98 in Stock https://t.co/00bi2ARVoJ #stocks
May 9th 2019, 6:05pm
InsiderAlertsIA @InsiderAlertsIA
$MNTA: New Insider Filing on Chief HR and Inf. Officer JO ANN BELTRAMELLO: https://t.co/USRzguNwYS
May 9th 2019, 4:05pm
Allstocknews @Allstocknews
$MNTA New Form 4 for Momenta Pharmaceuticals From our Stock News Alerts App
May 9th 2019, 4:05pm
StockTexts @StockTexts
$MNTA Momenta Pharmaceuticals, Inc. SEC Filing: Form 4 https://t.co/GyEswfGJnN
May 9th 2019, 4:05pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.